Literature DB >> 25751202

Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage.

Azar Mehrabadi1, Jennifer A Hutcheon, Shiliang Liu, Sharon Bartholomew, Michael S Kramer, Robert M Liston, K S Joseph.   

Abstract

OBJECTIVE: To quantify the contribution of placenta accreta to the rate of postpartum hemorrhage and severe postpartum hemorrhage.
METHODS: All hospital deliveries in Canada (excluding Quebec) for the years 2009 and 2010 (N=570,637) were included in a retrospective cohort study using data from the Canadian Institute for Health Information. Placenta accreta included placental adhesion to the uterine wall, musculature, and surrounding organs (accreta, increta, or percreta). Severe postpartum hemorrhage included postpartum hemorrhage with blood transfusion, hysterectomy, or other procedures to control bleeding (including uterine suturing and ligation or embolization of pelvic arteries). Rates, rate ratios, population-attributable fractions (ie, incidence of postpartum hemorrhage attributable to placenta accreta), and 95% confidence intervals (CIs) were estimated. Logistic regression was used to quantify associations between placenta accreta and risk factors.
RESULTS: The incidence of placenta accreta was 14.4 (95% CI 13.4-15.4) per 10,000 deliveries (819 cases among 570,637 deliveries), whereas the incidence of placenta accreta with postpartum hemorrhage was 7.2 (95% CI 6.5-8.0) per 10,000 deliveries. Postpartum hemorrhage among women with placenta accreta was predominantly third-stage hemorrhage (41% of all cases). Although placenta accreta was strongly associated with postpartum hemorrhage (rate ratio 8.3, 95% CI 7.7-8.9), its low frequency resulted in a small population-attributable fraction (1.0%, 95% CI 0.93-1.16). However, the strong association between placenta accreta and postpartum hemorrhage with hysterectomy (rate ratio 286, 95% CI 226-361) resulted in a population-attributable fraction of 29.0% (95% CI 24.3-34.3).
CONCLUSION: Placenta accreta is too infrequent to account for the recent temporal increase in postpartum hemorrhage but contributes substantially to the proportion of postpartum hemorrhage with hysterectomy.

Entities:  

Mesh:

Year:  2015        PMID: 25751202     DOI: 10.1097/AOG.0000000000000722

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  13 in total

Review 1.  The role of interventional radiology in the management of abnormally invasive placenta: a systematic review of current evidences.

Authors:  Philippe Soyer; Maxime Barat; Romaric Loffroy; Matthias Barral; Raphael Dautry; Vincent Vidal; Olivier Pellerin; Francois Cornelis; Maureen P Kohi; Anthony Dohan
Journal:  Quant Imaging Med Surg       Date:  2020-06

2.  Value of ultrasound scoring system for assessing risk of pernicious placenta previa with accreta spectrum disorders and poor pregnancy outcomes.

Authors:  Lingling Zhu; Limei Xie
Journal:  J Med Ultrason (2001)       Date:  2019-08-07       Impact factor: 1.314

3.  Cardiovascular disease and cancer in women with accreta and retained placenta: a longitudinal cohort study.

Authors:  Nathalie Auger; Sophie Marcoux; Gilles Paradis; Jessica Healy-Profitós; Shu Qin Wei; Brian J Potter
Journal:  Arch Gynecol Obstet       Date:  2021-04-04       Impact factor: 2.344

4.  MRI of placenta accreta: diagnostic accuracy and impact of interventional radiology on foetal-maternal delivery outcomes in high-risk women.

Authors:  Federica Fiocchi; Filippo Monelli; Giulia Besutti; Federico Casari; Elisabetta Petrella; Annarita Pecchi; Cristian Caporali; Emma Bertucci; Stefano Busani; Laura Botticelli; Fabio Facchinetti; Pietro Torricelli
Journal:  Br J Radiol       Date:  2020-07-29       Impact factor: 3.039

Review 5.  Therapeutic effect of Internal iliac artery ligation and uterine artery ligation techniques for bleeding control in placenta accreta spectrum patients: A meta-analysis of 795 patients.

Authors:  Ayman Essa Nabhan; Yossef Hassan AbdelQadir; Yomna Ali Abdelghafar; Muataz Omar Kashbour; Nour Salem; Abdelrahman Naeim Abdelkhalek; Anas Zakarya Nourelden; Mona Muhe Eldeen Eshag; Jaffer Shah
Journal:  Front Surg       Date:  2022-09-01

6.  Treatment of Morbidly Adherent Placentation Utilizing a Standardized Multidisciplinary Approach in the Community Hospital-Private Practice Setting.

Authors:  Mahsa Mansouri; Kim DeStefano; Brian Monks; Jasbir Singh; Mollie McDonnold; Jamison Morgan; Richard Hale; Jasvant Adusumalli; Amanda Horton; Sina Haeri
Journal:  AJP Rep       Date:  2017-11-22

7.  Grade Prediction of Bleeding Volume in Cesarean Section of Patients With Pernicious Placenta Previa Based on Deep Learning.

Authors:  Jun Liu; Tao Wu; Yun Peng; Rongguang Luo
Journal:  Front Bioeng Biotechnol       Date:  2020-04-30

8.  Pregnancy-Related ICU Admissions From 2008 to 2016 in China: A First Multicenter Report.

Authors:  Zhiling Zhao; Songyun Han; Gaiqi Yao; Shuangling Li; Wenxiong Li; Yangyu Zhao; Jie Qiao; Jianxin Zhang; Junli Lu; Liyuan Tao; Yue Han
Journal:  Crit Care Med       Date:  2018-10       Impact factor: 7.598

9.  Protrusion of placental tissue through the cervical os as an unusual presentation of placenta accreta: A case report.

Authors:  Anna Marie Pacheco Young; Katelyn Uribe; Angela K Shaddeau
Journal:  Case Rep Womens Health       Date:  2021-06-10

10.  Hysterectomy with Fetus In Situ for Uterine Rupture at 21-Week Gestation due to a Morbidly Adherent Placenta.

Authors:  Katerina Pizzuto; Cory Ozimok; Radenka Bozanovic; Kathleen Tafler; Sarah Scattolon; Nicholas A Leyland; Michelle Morais
Journal:  Case Rep Obstet Gynecol       Date:  2018-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.